Cognitive Impairment in Multiple Sclerosis and the Importance of Life Force Energy
Multiple Sclerosis (MS) is a chronic inflammatory and neurodegenerative autoimmune disease which affects the brain and the central nervous system. In MS, the immune system attacks the protective myelin sheath that covers nerve fibers, interrupting communication between the brain and the body, which may result in symptoms¹ such as:
• Visual impairment or loss in one or both eyes, typically one eye at a time, and pain with eye movement
• Prolonged double vision
• Balance and coordination issues, tremor, unsteady gait
• Muscle weakness
• Slurred speech
• Fatigue
• Dizziness
• Bowel and bladder control issues
• Depression
• Numbness, prickling, or “pins and needles” in the extremities
• Cognitive impairment or memory issues, also called “brain fog” or “cog fog”
Devin Garlit knows all about the ‘cog fog’ that can come with MS. As a software engineer who was diagnosed with MS when he was just 21 years old, he writes candidly about the cognitive impairment that he struggles with. He states:²
“…I was more forgetful; I was distracted much more easily. Things that were easy to blame on aging or stress. I thought, “oh, I’m not as young as I used to be, that’s all.” I was still good at what I did, more than enough to get by, but I knew I wasn’t the same. My brain was never as sharp or as fast. I felt like my head was in a cloud for long periods of time. Then, in the span of a couple months in my mid-30s, things suddenly got much worse. I’d get lost going to work, I’d have no idea what I was doing at times, or even where I was. Forget about being about to write complex computer code, I could barely handle basic everyday functions and taking care of myself.”
Devin is not alone in his struggle to remember, or to handle the everyday functions of life. MS affects approximately 600,000 people in the US, and over 2 million people worldwide.³ Of this population, up to 65% will experience some form of ‘cog fog,’ to varying degrees, with 10% of the population experiencing significant, debilitating cognitive issues.⁴ Cognitive functions especially at risk⁵ include:
• Sensory information processing
• Memory: acquiring, retaining, and retrieving
• Attention and concentration abilities, especially when there are distractions present
• Executive functions like planning, organizing, or prioritizing
• Visual perception
• Verbal fluency and ‘finding words’
Further, women are typically three times more likely to be struck with MS as opposed to men,⁶ and while the disease tends to hit between 30–35 years of age, it can strike as young as 15 and late as 60.⁷
According to the American Journal of Managed Care, the healthcare costs of managing MS are substantial: over 10 billion dollars per year⁸ in the US alone. Given that up to 75% of people with MS leave the workforce within ten years after their diagnosis⁹ and cite cognitive impairment as the reason,¹⁰ one begins to understand the impact of this disease in both broad economic terms as well as personal quality of life issues, lessened productivity, and the potentially profound burden on the family or caregivers of the person who is diagnosed.
For the last 30 years, conventional therapies for MS have included long term immunosuppressant drugs such as Azathioprine¹¹- traditionally used to prevent rejection after a kidney transplant; Cyclophosphamide¹²- traditionally a chemotherapy drug used for cancer; Methotrexate¹³- an anti-cancer drug also used for Rheumatoid Arthritis; and Mitoxantrone¹⁴- another anti-cancer drug. Sadly, these immunosuppressants “pose increased risks for infections and cancer”¹⁵ among many other profound and unwanted side effects.
Other treatment options (or co-treatment options) involve disease-modifying therapies¹⁶ such as:
• Interferons
• Glatiramer acetate
• Monoclonal antibodies
• Sphingosine-1-phosphate receptor modulators
These therapies are known to dramatically reduce the number of attacks and decrease the progression of the disease;¹⁷ however, they do not alleviate symptoms and also bring many unwanted side effects, such as “suicidal thoughts, hallucinations, seizures, and heart and liver problems,”¹⁸ to name just a few.
Omega 3 Fatty Acids
Omega 3 Fatty Acids have been shown to reduce inflammation,¹⁹ which is a key feature in relapsing types of MS, yet there are few studies available which test Omega 3’s in conjunction with MS and its symptoms, particularly cognitive decline. One of the few studies that was done found that those who took Omega 3’s experienced a subjective reduction in the severity of their disease, however the results were not statistically significant.²⁰
Ginkgo Biloba
Ginkgo Biloba is an herb extracted from the leaves of the Gingko Tree, one of the oldest species of trees on the planet. It has been touted as a memory enhancer, and a brain support supplement for thousands of years.²¹ There is at least one study relating Ginkgo Biloba as being helpful for those with MS, stating that the herb lessened fatigue and the severity of symptoms.²² However, another test, this one a double blind study, confirmed that Ginkgo Biloba was not effective in the treatment of cognitive decline in MS.²³
Ginkgo was the top selling herbal supplement of 2011, with a revenue total of $90 million.²⁴ That’s a lot of people potentially hoping that Ginkgo might work in cases of serious disease processes.
Vitamin D3
According to the journal, Neurosciences,²⁵ Vitamin D is a fat soluble vitamin with two main forms: a plant based (and less bioactive form) known as Vitamin D2, and an animal based form, called Vitamin D3. While Vitamin D can be found in foods such as fish, dairy, fortified foods, and supplements, our main source of Vitamin D is having our skin exposed to sunlight. Total body sun exposure can easily provide 10,000IU of Vitamin D, which is converted by the skin with the ultraviolet rays of the sun into Vitamin D3. This is converted in the liver and then the kidney into the hormone calcitriol, which is the most bioactive form of Vitamin D. Calcitriol is also what binds to the Vitamin D receptor site in the cell, ensuring that the Vitamin D is delivered from the blood stream directly into the cell where it is needed. The same journal also states, “Vitamin D receptor-binding elements have been identified in the majority of MS-associated genes, indicating that the expression of many of these genes may be regulated by vitamin D.”²⁶
Interestingly, statistics show that people who live in the northern latitudes, and thus receive less sunlight, are more susceptible to getting MS than those who live in sunny climates closer to the equator, and there has been a definitive link found between people who suffer from MS and Vitamin D deficiency.²⁷ The issue concerning Vitamin D3 now is that humans seem to be less and less able to synthesize and absorb Vitamin D3, no matter if it is through supplementation or direct sunlight.²⁸ With lowered bioavailability, people simply aren’t absorbing as much D3 as they need, regardless of how many capsules they take. This has disturbing implications not only for MS patients, but for humanity as a whole.
The Trivedi Effect® is a new scientific paradigm based upon the miraculous work of Guruji Mahendra Trivedi, who has the ability to both harness and transmit Life Force Energy. This profound, nature-based phenomenon has the ability to transform human health at all levels of being, raise consciousness, and connect people more deeply to the God of their Understanding.
In a lab setting, it was discovered that the Trivedi Effect® had the ability kill cancer cells, but at the same time enhance the viability of healthy cells,²⁹ proving beyond doubt that this Energy is both powerful and Intelligent. There are currently well over 4000 scientific experiments³⁰ that have been done regarding The Trivedi Effect®. These studies are astonishing scientists worldwide, for this new paradigm is directly merging science and spirituality. It is directly proving the existence of a Higher, Divine Intelligence at work. The extraordinary results from these experiments have, to date, been published in over 350 peer-reviewed science journals and are now available to review on The National Institutes of Health website, as well as in leading ivy league university libraries around the world.
Imagine that instead of degenerating, you — or a loved one — begins to regenerate and experience a decrease in symptoms and an increase in energy and functionality in daily life. Imagine your memory returning, the synapses igniting and communication happening so the sought after information can now make the leap into your awareness. Imagine your brain functioning properly again. This is the realm of miracles, the realm of The Trivedi Effect®, and it is all currently being documented and recorded scientifically using the most advanced equipment available on the planet today.
If you or a loved one are suffering from MS and/or the cognitive issues that can come with this disease, take heart. There is a new paradigm on the horizon that can have a profoundly healing impact on your cognition, overall health, and all areas of your life — without harmful side effects.
For more information about The Trivedi Effect®, please visit trivedieffect.com.
[1]https://www.mayoclinic.org/diseases-conditions/multiple-sclerosis/symptoms-causes/syc-20350269?p=1
[2]Garlit, Devin, Devin Garlit. 2012–2018 https://multiplesclerosis.net/community/experts/devin-garlit/.
[3]Rahn, K., Slusher, B., & Kaplin, A. (2012). Cognitive Impairment in Multiple Sclerosis: A Forgotten Disability Remembered. Cerebrum: The Dana Forum on Brain Science,2012, 14.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3574761/
[4]http://www.agis.com/Document/778/fact-sheet—multiple-sclerosis.aspx
[5]https://www.nationalmssociety.org/Symptoms-Diagnosis/MS-Symptoms/Cognitive-Changes
[6]Dilokthornsakul, P., Valuck, R. J., Nair, K. V., Corboy, J. R., Allen, R. R., & Campbell, J. D. (2016). Multiple sclerosis prevalence in the United States commercially insured population. Neurology, 86(11), 1014–1021. http://doi.org/10.1212/WNL.0000000000002469
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4799713/
[7]https://www.mayoclinic.org/diseases-conditions/multiple-sclerosis/symptoms-causes/syc-20350269
[8]Howard L. Zwibel, Howard L., MD and Smrtka, Jennifer, MSN, ANP-BC, MSCN. Improving Quality of Life in Multiple Sclerosis: An Unmet Need. AMJC. https://www.ncbi.nlm.nih.gov/pubmed/21761952
[9]Julian, L. J., Vella, L., Vollmer, T., Hadjimichael, O., & Mohr, D. C. (2008). Employment in multiple sclerosis. Exiting and re-entering the work force. Journal of Neurology, 255(9), 1354–1360.
[10]Larocca, N., Kalb, R., Scheinberg, L., & Kendall, P. (1985). Factors associated with unemployment of patients with multiple sclerosis. Journal of Chronic Diseases, 38(2), 203–210.
[11]https://www.mayoclinic.org/drugs-supplements/azathioprine-oral-route/description/drg-20067180
[12]US National Library of Medicine. Cyclophosphamide. https://medlineplus.gov/druginfo/meds/a682080.html
[13]US National Library of Medicine. Methotrexate. https://medlineplus.gov/druginfo/meds/a682019.html
[14] Weiner, Howard L., Immunosuppressive treatment in multiple sclerosis. Journal of the Neurological Sciences, Volume 223, Issue 1, 15 August 2004, Pages 1–11. DOI: https://doi.org/10.1016/j.jns.2004.04.013. https://www.jns-journal.com/article/S0022-510X(04)00113-3/fulltext
[15]Dargahi, N., Katsara, M., Tselios, T., Androutsou, M.-E., de Courten, M., Matsoukas, J., & Apostolopoulos, V. (2017). Multiple Sclerosis: Immunopathology and Treatment Update. Brain Sciences, 7(7), 78. http://doi.org/10.3390/brainsci7070078. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5532591/
[16]Ibid.
[17]Ibid.
[18]Katsara M, Matsoukas J, Deraos G, Apostolopoulos V Acta Biochim Biophys Sin (Shanghai). 2008 Jul; 40(7):636–42.https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5532591/
[19]Calder, Philip C. Omega-3 fatty acids and inflammatory processes: from molecules to man. Biochemical Society Transactions, Sep 12, 2017, 45 (5) 1105–1115; DOI: 10.1042/BST20160474. https://www.ncbi.nlm.nih.gov/pubmed/28900017
[20]Yadav, V., Shinto, L., & Bourdette, D. (2010). Complementary and alternative medicine for the treatment of multiple sclerosis. Expert Review of Clinical Immunology,6(3), 381–395. http://doi.org/10.1586/eci.10.12https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2901236/
[21]NIH: National Center for Complementary and IntegrativeHealth. Gingko. https://nccih.nih.gov/health/ginkgo/ataglance.htm
[22]Susan K.Johnson, PhD, Bruce J.Diamond, PhD, SaraRauschMS, MichaelKaufmanMD, Samuel C.ShiflettPhD, LindaGravesMD. The Effect of Ginkgo Bilobaon Functional Measures in Multiple Sclerosis: A Pilot Randomized Controlled Trial. EXPLORE: The Journal of Science and Healing, Volume 2, Issue 1, January 2006, Pages 19–24. https://doi.org/10.1016/j.explore.2005.10.007https://www.ncbi.nlm.nih.gov/pubmed/16781604
[23]Lovera, J. F., Kim, E., Heriza, E., Fitzpatrick, M., Hunziker, J., Turner, A. P., … Bourdette, D. (2012). Ginkgo Biloba does not improve cognitive function in MS: A randomized placebo-controlled trial. Neurology, 79(12), 1278–1284. http://doi.org/10.1212/WNL.0b013e31826aac60https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3440446/
[24]Gafner, Stefan. Adulteration of Gingko Biloba Leaf Extracts. Botanical Adulturants Bulletin, 2018. https://www.naturalproductsinsider.com/herbs-botanicals/cspi-consumers-avoid-ginkgo-biloba-supplements
[25]Alharbi, F. M. (2015). Update in vitamin D and multiple sclerosis. Neurosciences, 20(4), 329–335. http://doi.org/10.17712/nsj.2015.4.20150357https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4727614/
[26]Ibid.
[27]Ibid.
[28]Grossmann, R. E., & Tangpricha, V. (2010). Evaluation of vehicle substances on vitamin D bioavailability: A systematic review. Molecular Nutrition & Food Research,54(8), 1055–1061. http://doi.org/10.1002/mnfr.200900578.https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3033429/
[29]Trivedi MK, Patil S, Shettigar H, Mondal SC, Jana S (2015) The Potential Impact of Biofield Treatment on Human Brain Tumor Cells: A Time- Lapse Video Microscopy. J Integr Oncol 4: 141. doi:10.4172/2329–6771.1000141. https://www.trivedieffect.com/the-science/publications/cancer-publications/the-potential-impact-of-biofield-treatment-on-human-brain-tumor-cells-a-time-lapse-video-microscopy/
[30]https://www.trivedieffect.com/the-science/
Cognitive Impairment in Multiple Sclerosis and the Importance of Life Force Energy
Research & References of Cognitive Impairment in Multiple Sclerosis and the Importance of Life Force Energy|A&C Accounting And Tax Services
Source
0 Comments